ProAssurance Co. (NYSE:PRA) Receives $18.67 Consensus PT from Brokerages

ProAssurance Co. (NYSE:PRAGet Free Report) has received a consensus recommendation of “Hold” from the five research firms that are covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $18.67.

PRA has been the subject of a number of research reports. Citizens Jmp cut shares of ProAssurance from an “outperform” rating to a “market perform” rating in a report on Thursday, April 3rd. StockNews.com initiated coverage on shares of ProAssurance in a research report on Wednesday. They set a “hold” rating on the stock. Finally, Citigroup lowered ProAssurance to a “market perform” rating in a research report on Thursday, April 3rd.

Get Our Latest Stock Report on ProAssurance

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Mariner LLC lifted its position in ProAssurance by 4.2% in the 4th quarter. Mariner LLC now owns 17,007 shares of the insurance provider’s stock valued at $271,000 after acquiring an additional 688 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of ProAssurance by 4.0% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 28,991 shares of the insurance provider’s stock worth $461,000 after purchasing an additional 1,127 shares during the last quarter. Rhumbline Advisers lifted its holdings in shares of ProAssurance by 0.8% in the fourth quarter. Rhumbline Advisers now owns 160,707 shares of the insurance provider’s stock valued at $2,557,000 after purchasing an additional 1,281 shares in the last quarter. Sterling Capital Management LLC lifted its holdings in shares of ProAssurance by 859.4% in the fourth quarter. Sterling Capital Management LLC now owns 1,631 shares of the insurance provider’s stock valued at $26,000 after purchasing an additional 1,461 shares in the last quarter. Finally, KBC Group NV boosted its position in shares of ProAssurance by 75.4% during the fourth quarter. KBC Group NV now owns 4,184 shares of the insurance provider’s stock valued at $67,000 after buying an additional 1,798 shares during the last quarter. 85.58% of the stock is currently owned by institutional investors and hedge funds.

ProAssurance Stock Up 0.4 %

Shares of ProAssurance stock opened at $23.16 on Monday. The stock’s 50-day moving average is $17.87 and its 200 day moving average is $16.43. ProAssurance has a one year low of $10.76 and a one year high of $23.70. The firm has a market cap of $1.18 billion, a price-to-earnings ratio of 27.90 and a beta of -0.09. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.28 and a quick ratio of 0.28.

ProAssurance (NYSE:PRAGet Free Report) last posted its quarterly earnings results on Monday, February 24th. The insurance provider reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.19. The firm had revenue of $287.52 million for the quarter, compared to analysts’ expectations of $274.56 million. ProAssurance had a return on equity of 2.65% and a net margin of 3.71%. Equities research analysts anticipate that ProAssurance will post 0.8 EPS for the current year.

ProAssurance Company Profile

(Get Free Report

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.

Featured Articles

Analyst Recommendations for ProAssurance (NYSE:PRA)

Receive News & Ratings for ProAssurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProAssurance and related companies with MarketBeat.com's FREE daily email newsletter.